Amyloidosis Therapeutics Market Report

Amyloidosis Therapeutics Market - Global Professional Analysis and Forecast to 2026

  • POSTDATE：Jan 24, 2020
  • PAGES：145
  • REPORT CODE：GMM446586
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The worldwide Amyloidosis Therapeutics market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 4.5% during the forecast period.

    This report presents the market size and development trends by detailing the Amyloidosis Therapeutics market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Amyloidosis Therapeutics market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Amyloidosis Therapeutics industry and will help you to build a panoramic view of the industrial development.

    Amyloidosis Therapeutics Market, By Type:

    • AG-10

    • ALN-ANG

    • ALN-TTRsc02

    • CAEL-101

    • canakinumab

    • Others

    Amyloidosis Therapeutics Market, By Application:

    • AL amyloidosis

    • AA amyloidoses

    • ATTR amyloidoses

    • Others

    Some of the leading players are as follows:

    • Pfizer Inc

    • ProteoTech, Inc

    • Bsim2.

    • Celgene Corporation.

    • Onyx Pharmaceuticals, Inc.

    • Arcturus Therapeutics, Inc

    • GlaxoSmithKline Plc

    • Bellus Health Inc.

    • Millennium Pharmaceuticals, Inc.

    • Prothena Corporation Plc.

    • SOM Innovation Biotech SL

    • Isis Pharmaceuticals, Inc

    • Alnylam Pharmaceuticals, Inc.

    Geographically, Major regions are analyzed in details are as follows:

    • North America

    • Europe

    • Asia Pacific

    • Latin America

    • Middle East & Africa

  • Table of Contents

    1 Methodology and Scope

    • 1.1 Market Segmentation & Scope

      • 1.1.1 Technology Type

      • 1.1.2 Product

      • 1.1.3 Application

      • 1.1.4 Regional scope

      • 1.1.5 Estimates and forecast timeline

    • 1.2 Research Methodology

    • 1.3 Information Procurement

      • 1.3.1 Purchased database

      • 1.3.2 Internal database

      • 1.3.3 Secondary sources

      • 1.3.4 Primary research

      • 1.3.5 Details of primary research

    • 1.4 Information or Data Analysis

      • 1.4.1 Data analysis models

    • 1.5 Market Formulation & Validation

    • 1.6 Model Details

      • 1.6.1 Commodity flow analysis

      • 1.6.2 Volume price analysis

    • 1.7 List of Secondary Sources

    • 1.8 List of Abbreviations

    2 Executive Summary

    • 2.1 Market Outlook

    • 2.2 Segment Outlook

    3 Market Variables, Trends, & Scope

    • 3.1 Market Lineage Outlook

    • 3.1.1 Parent market outlook

      • 3.1.2 Ancillary market outlook

    • 3.2 Market Segmentation

      • 3.2.1 Analysis

    • 3.3 Market Dynamics

      • 3.3.1 Market driver analysis

      • 3.3.2 Market restraint analysis

      • 3.3.3 Industry opportunities

    • 3.4 Penetration & Growth Prospect Mapping

      • 3.4.1 Penetration & growth prospect mapping analysis

    • 3.5 Business Environment Analysis Tools

      • 3.5.1 Porter's five forces analysis

      • 3.5.2 PESTLE analysis

      • 3.5.3 Major deals & strategic alliances analysis

    4 Amyloidosis Therapeutics Market: Technology Type Analysis

    • 4.1 Amyloidosis Therapeutics Technology Type Market Share Analysis, 2018 & 2026

    • 4.2 Amyloidosis Therapeutics Technology Type Market: Segment Dashboard

    • 4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment

      • 4.3.1 AG-10

      • 4.3.2 ALN-ANG

      • 4.3.3 ALN-TTRsc02

      • 4.3.4 CAEL-101

      • 4.3.5 canakinumab

      • 4.3.6 Others

    5 Amyloidosis Therapeutics Market: Product Analysis

    • 5.1 Amyloidosis Therapeutics Product Market Share Analysis, 2018 & 2026

    • 5.2 Amyloidosis Therapeutics Product Market: Segment Dashboard

    • 5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment

    6 Amyloidosis Therapeutics Market: Application Analysis

    • 6.1 Amyloidosis Therapeutics Application Market Share Analysis, 2018 & 2026

    • 6.2 Amyloidosis Therapeutics Application Market: Segment Dashboard

    • 6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment

      • 6.3.1 AL amyloidosis

      • 6.3.2 AA amyloidoses

      • 6.3.3 ATTR amyloidoses

      • 6.3.4 Others

    7 Amyloidosis Therapeutics Market: Regional Analysis

    • 7.1 Amyloidosis Therapeutics Regional Market Share Analysis, 2018 & 2026

    • 7.2 Amyloidosis Therapeutics Regional Market: Segment Dashboard

    • 7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)

    • 7.4 List of Players at Regional Level

      • 7.4.1 North America

      • 7.4.2 Europe

      • 7.4.3 Asia Pacific

    • 7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)

      • 7.5.1 North America

      • 7.5.2 Europe

      • 7.5.3 Asia Pacific

      • 7.5.4 Latin America

      • 7.5.5 MEA

    • 7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026

      • 7.6.1 North America

      • 7.6.2 Europe

      • 7.6.3 Asia Pacific

      • 7.6.4 Latin America

      • 7.6.5 Middle East & Africa

    8 Competitive Analysis

    • 8.1 Recent Developments & Impact Analysis, by Key Market Participants

    • 8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)

    • 8.3 Vendor Landscape

      • 8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)

    9 Company Profiles

    • 9.1 Pfizer Inc

      • 9.1.1 Pfizer Inc Company overview

      • 9.1.2 Financial performance

      • 9.1.3 Product benchmarking

      • 9.1.4 Strategic initiatives

      • 9.1.5 SWOT analysis

    • 9.2 ProteoTech, Inc

      • 9.2.1 ProteoTech, Inc Company overview

      • 9.2.2 Financial performance

      • 9.2.3 Product benchmarking

      • 9.2.4 Strategic initiatives

      • 9.2.5 SWOT analysis

    • 9.3 Bsim2.

      • 9.3.1 Bsim2. Company overview

      • 9.3.2 Financial performance

      • 9.3.3 Product benchmarking

      • 9.3.4 Strategic initiatives

      • 9.3.5 SWOT analysis

    • 9.4 Celgene Corporation.

      • 9.4.1 Celgene Corporation. Company overview

      • 9.4.2 Financial performance

      • 9.4.3 Product benchmarking

      • 9.4.4 Strategic initiatives

      • 9.4.5 SWOT analysis

    • 9.5 Onyx Pharmaceuticals, Inc.

      • 9.5.1 Onyx Pharmaceuticals, Inc. Company overview

      • 9.5.2 Financial performance

      • 9.5.3 Product benchmarking

      • 9.5.4 Strategic initiatives

      • 9.5.5 SWOT analysis

    • 9.6 Arcturus Therapeutics, Inc

      • 9.6.1 Arcturus Therapeutics, Inc Company overview

      • 9.6.2 Financial performance

      • 9.6.3 Product benchmarking

      • 9.6.4 Strategic initiatives

      • 9.6.5 SWOT analysis

    • 9.7 GlaxoSmithKline Plc

      • 9.7.1 GlaxoSmithKline Plc Company overview

      • 9.7.2 Financial performance

      • 9.7.3 Product benchmarking

      • 9.7.4 Strategic initiatives

      • 9.7.5 SWOT analysis

    • 9.8 Bellus Health Inc.

      • 9.8.1 Bellus Health Inc. Company overview

      • 9.8.2 Financial performance

      • 9.8.3 Product benchmarking

      • 9.8.4 Strategic initiatives

      • 9.8.5 SWOT analysis

    • 9.9 Millennium Pharmaceuticals, Inc.

      • 9.9.1 Millennium Pharmaceuticals, Inc. Company overview

      • 9.9.2 Financial performance

      • 9.9.3 Product benchmarking

      • 9.9.4 Strategic initiatives

      • 9.9.5 SWOT analysis

    • 9.10 Prothena Corporation Plc.

      • 9.10.1 Prothena Corporation Plc. Company overview

      • 9.10.2 Financial performance

      • 9.10.3 Product benchmarking

      • 9.10.4 Strategic initiatives

      • 9.10.5 SWOT analysis

    • 9.11 SOM Innovation Biotech SL

      • 9.11.1 SOM Innovation Biotech SL Company overview

      • 9.11.2 Financial performance

      • 9.11.3 Product benchmarking

      • 9.11.4 Strategic initiatives

      • 9.11.5 SWOT analysis

    • 9.12 Isis Pharmaceuticals, Inc

      • 9.12.1 Isis Pharmaceuticals, Inc Company overview

      • 9.12.2 Financial performance

      • 9.12.3 Product benchmarking

      • 9.12.4 Strategic initiatives

      • 9.12.5 SWOT analysis

    • 9.13 Alnylam Pharmaceuticals, Inc.

      • 9.13.1 Alnylam Pharmaceuticals, Inc. Company overview

      • 9.13.2 Financial performance

      • 9.13.3 Product benchmarking

      • 9.13.4 Strategic initiatives

      • 9.13.5 SWOT analysis

     

    The List of Tables and Figures (Totals 61 Figures and 126 Tables)

    • Figure AG-10 Amyloidosis Therapeutics market, 2015 - 2026 (USD Million)

    • Figure ALN-ANG Amyloidosis Therapeutics market, 2015 - 2026 (USD Million)

    • Figure ALN-TTRsc02 Amyloidosis Therapeutics market, 2015 - 2026 (USD Million)

    • Figure CAEL-101 Amyloidosis Therapeutics market, 2015 - 2026 (USD Million)

    • Figure canakinumab Amyloidosis Therapeutics market, 2015 - 2026 (USD Million)

    • Figure Others Amyloidosis Therapeutics market, 2015 - 2026 (USD Million)

    • Figure AL amyloidosis market, 2015 - 2026 (USD Million)

    • Figure AA amyloidoses market, 2015 - 2026 (USD Million)

    • Figure ATTR amyloidoses market, 2015 - 2026 (USD Million)

    • Figure Others market, 2015 - 2026 (USD Million)

    • Table List of players in North America

    • Table List of players in Europe

    • Table List of players in Asia Pacific

    • Table SWOT analysis

    • Table North America Amyloidosis Therapeutics market, by country, 2015 - 2026 (USD Million)

    • Table North America Amyloidosis Therapeutics market, by type, 2015 - 2026 (USD Million)

    • Table North America Amyloidosis Therapeutics market, by product, 2015 - 2026 (USD Million)

    • Table North America Amyloidosis Therapeutics market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table U.S. Amyloidosis Therapeutics market, by type, 2015 - 2026 (USD Million)

    • Table U.S. Amyloidosis Therapeutics market, by product, 2015 - 2026 (USD Million)

    • Table U.S. Amyloidosis Therapeutics market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Canada Amyloidosis Therapeutics market, by type, 2015 - 2026 (USD Million)

    • Table Canada Amyloidosis Therapeutics market, by product, 2015 - 2026 (USD Million)

    • Table Canada Amyloidosis Therapeutics market, by application, 2015 - 2026 (USD Million)

    • Table Europe Amyloidosis Therapeutics market, by country, 2015 - 2026 (USD Million)

    • Table Europe Amyloidosis Therapeutics market, by type, 2015 - 2026 (USD Million)

    • Table Europe Amyloidosis Therapeutics market, by product, 2015 - 2026 (USD Million)

    • Table Europe Amyloidosis Therapeutics market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table U.K. Amyloidosis Therapeutics market, by type, 2015 - 2026 (USD Million)

    • Table U.K. Amyloidosis Therapeutics market, by product, 2015 - 2026 (USD Million)

    • Table U.K. Amyloidosis Therapeutics market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Germany Amyloidosis Therapeutics market, by type, 2015 - 2026 (USD Million)

    • Table Germany Amyloidosis Therapeutics market, by product, 2015 - 2026 (USD Million)

    • Table Germany Amyloidosis Therapeutics market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table France Amyloidosis Therapeutics market, by type, 2015 - 2026 (USD Million)

    • Table France Amyloidosis Therapeutics market, by product, 2015 - 2026 (USD Million)

    • Table France Amyloidosis Therapeutics market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Italy Amyloidosis Therapeutics market, by type, 2015 - 2026 (USD Million)

    • Table Italy Amyloidosis Therapeutics market, by product, 2015 - 2026 (USD Million)

    • Table Italy Amyloidosis Therapeutics market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Spain Amyloidosis Therapeutics market, by type, 2015 - 2026 (USD Million)

    • Table Spain Amyloidosis Therapeutics market, by product, 2015 - 2026 (USD Million)

    • Table Spain Amyloidosis Therapeutics market, by application, 2015 - 2026 (USD Million)

    • Table Asia Pacific Amyloidosis Therapeutics market, by country, 2015 - 2026 (USD Million)

    • Table Asia Pacific Amyloidosis Therapeutics market, by type, 2015 - 2026 (USD Million)

    • Table Asia Pacific Amyloidosis Therapeutics market, by product, 2015 - 2026 (USD Million)

    • Table Asia Pacific Amyloidosis Therapeutics market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table China Amyloidosis Therapeutics market, by type, 2015 - 2026 (USD Million)

    • Table China Amyloidosis Therapeutics market, by product, 2015 - 2026 (USD Million)

    • Table China Amyloidosis Therapeutics market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Japan Amyloidosis Therapeutics market, by type, 2015 - 2026 (USD Million)

    • Table Japan Amyloidosis Therapeutics market, by product, 2015 - 2026 (USD Million)

    • Table Japan Amyloidosis Therapeutics market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table India Amyloidosis Therapeutics market, by type, 2015 - 2026 (USD Million)

    • Table India Amyloidosis Therapeutics market, by product, 2015 - 2026 (USD Million)

    • Table India Amyloidosis Therapeutics market, by application, 2015 - 2026 (USD Million)

    • Table Latin America Amyloidosis Therapeutics market, by country, 2015 - 2026 (USD Million)

    • Table Latin America Amyloidosis Therapeutics market, by type, 2015 - 2026 (USD Million)

    • Table Latin America Amyloidosis Therapeutics market, by product, 2015 - 2026 (USD Million)

    • Table Latin America Amyloidosis Therapeutics market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Brazil Amyloidosis Therapeutics market, by type, 2015 - 2026 (USD Million)

    • Table Brazil Amyloidosis Therapeutics market, by product, 2015 - 2026 (USD Million)

    • Table Brazil Amyloidosis Therapeutics market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Mexico Amyloidosis Therapeutics market, by type, 2015 - 2026 (USD Million)

    • Table Mexico Amyloidosis Therapeutics market, by product, 2015 - 2026 (USD Million)

    • Table Mexico Amyloidosis Therapeutics market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Argentina Amyloidosis Therapeutics market, by type, 2015 - 2026 (USD Million)

    • Table Argentina Amyloidosis Therapeutics market, by product, 2015 - 2026 (USD Million)

    • Table Argentina Amyloidosis Therapeutics market, by application, 2015 - 2026 (USD Million)

    • Table MEA Amyloidosis Therapeutics market, by country, 2015 - 2026 (USD Million)

    • Table MEA Amyloidosis Therapeutics market, by type, 2015 - 2026 (USD Million)

    • Table MEA Amyloidosis Therapeutics market, by product, 2015 - 2026 (USD Million)

    • Table MEA Amyloidosis Therapeutics market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table South Africa Amyloidosis Therapeutics market, by type, 2015 - 2026 (USD Million)

    • Table South Africa Amyloidosis Therapeutics market, by product, 2015 - 2026 (USD Million)

    • Table South Africa Amyloidosis Therapeutics market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Nigeria Amyloidosis Therapeutics market, by type, 2015 - 2026 (USD Million)

    • Table Nigeria Amyloidosis Therapeutics market, by product, 2015 - 2026 (USD Million)

    • Table Nigeria Amyloidosis Therapeutics market, by application, 2015 - 2026 (USD Million)

    • Table Recent Developments & Impact Analysis, by Key Market Participants

    • Table Recent Developments & Impact Analysis, by Key Market Participants

    • Table Company market position analysis

    • Table Company Profiles

    • Table Pfizer Inc Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table ProteoTech, Inc Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Bsim2. Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Celgene Corporation. Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Onyx Pharmaceuticals, Inc. Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Arcturus Therapeutics, Inc Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table GlaxoSmithKline Plc Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Bellus Health Inc. Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Millennium Pharmaceuticals, Inc. Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Prothena Corporation Plc. Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table SOM Innovation Biotech SL Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Isis Pharmaceuticals, Inc Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Alnylam Pharmaceuticals, Inc. Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US